Rate My Professor James Ziogas

James Ziogas's primary research interest is receptor pharmacology, encompassing areas such as drug metabolism using high-resolution mass spectrometry techniques like HiTIME for nontargeted detection of metabolites and stable isotope labelling, cardioprotection mechanisms, vasoconstriction via calcium channels and endothelin, ischemia-reperfusion injury, synthetic opioids residue analysis from drug paraphernalia, purinergic transmission, and neuroeffector interactions. He has authored 66 publications garnering over 1,700 citations. Notable publications include 'An evaluation of pharmacology curricula in Australian science and health-related degree programs' (2013), 'High-Resolution Twin-Ion Metabolite Extraction (HiTIME) Mass Spectrometry: Nontargeted Detection of Unknown Drug Metabolites' (2015), 'Aliskiren Reduces Myocardial Ischemia-Reperfusion Injury by a Bradykinin B2 Receptor- and Angiotensin AT2 Receptor-Mediated Mechanism' (2014), 'Trace Residue Identification, Characterization and Longitudinal Monitoring of the Novel Synthetic Opioid β-U10' (2022), and 'Using high-resolution Twin-Ion Metabolite Extraction (HiTIME) mass spectrometry with stable isotope labelling to investigate the metabolism of valproic acid in vivo' (2019). Ziogas contributes to clinical proteomics and interdisciplinary research teams advancing biomedical science.